A detailed history of Fjarde Ap Fonden transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Fjarde Ap Fonden holds 24,520 shares of DGX stock, worth $3.36 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
24,520
Previous 24,720 0.81%
Holding current value
$3.36 Million
Previous $3.41 Million 4.23%
% of portfolio
0.04%
Previous 0.04%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$123.78 - $142.11 $24,756 - $28,422
-200 Reduced 0.81%
24,520 $3.26 Million
Q4 2023

Feb 14, 2024

SELL
$120.62 - $141.12 $398,046 - $465,696
-3,300 Reduced 11.78%
24,720 $3.41 Million
Q3 2023

Oct 23, 2023

BUY
$121.86 - $144.92 $237,627 - $282,594
1,950 Added 7.48%
28,020 $3.41 Million
Q2 2023

Aug 02, 2023

SELL
$130.56 - $146.84 $2.75 Million - $3.1 Million
-21,100 Reduced 44.73%
26,070 $3.66 Million
Q1 2023

May 15, 2023

BUY
$131.53 - $155.76 $1.58 Million - $1.88 Million
12,050 Added 34.31%
47,170 $6.67 Million
Q4 2022

Feb 14, 2023

SELL
$123.31 - $157.26 $2.12 Million - $2.71 Million
-17,218 Reduced 32.9%
35,120 $5.49 Million
Q2 2022

Aug 11, 2022

BUY
$127.07 - $145.39 $1.12 Million - $1.28 Million
8,800 Added 20.21%
52,338 $6.96 Million
Q1 2022

May 13, 2022

BUY
$129.09 - $164.35 $428,966 - $546,135
3,323 Added 8.26%
43,538 $5.96 Million
Q4 2021

Feb 15, 2022

BUY
$140.36 - $173.01 $378,972 - $467,127
2,700 Added 7.2%
40,215 $6.96 Million
Q3 2021

Nov 15, 2021

SELL
$132.95 - $158.0 $558,390 - $663,600
-4,200 Reduced 10.07%
37,515 $5.45 Million
Q2 2021

Aug 12, 2021

SELL
$126.66 - $141.48 $785,292 - $877,175
-6,200 Reduced 12.94%
41,715 $5.51 Million
Q1 2021

May 17, 2021

BUY
$114.63 - $133.34 $630,465 - $733,370
5,500 Added 12.97%
47,915 $6.15 Million
Q3 2020

Nov 13, 2020

BUY
$107.05 - $130.01 $545,955 - $663,051
5,100 Added 13.67%
42,415 $4.86 Million
Q2 2020

Aug 13, 2020

SELL
$73.34 - $122.61 $330,030 - $551,745
-4,500 Reduced 10.76%
37,315 $4.25 Million
Q1 2020

May 11, 2020

SELL
$75.14 - $115.68 $60,112 - $92,544
-800 Reduced 1.88%
41,815 $3.36 Million
Q4 2019

Feb 10, 2020

BUY
$100.29 - $107.99 $882,552 - $950,312
8,800 Added 26.02%
42,615 $4.55 Million
Q3 2019

Oct 31, 2019

BUY
$97.85 - $107.42 $48,925 - $53,710
500 Added 1.5%
33,815 $3.62 Million
Q2 2019

Jul 17, 2019

SELL
$85.18 - $101.94 $860,318 - $1.03 Million
-10,100 Reduced 23.26%
33,315 $3.39 Million
Q1 2019

Apr 29, 2019

BUY
$80.68 - $89.92 $928,707 - $1.04 Million
11,511 Added 36.08%
43,415 $3.9 Million
Q4 2018

Jan 31, 2019

SELL
$79.75 - $108.38 $709,775 - $964,582
-8,900 Reduced 21.81%
31,904 $2.66 Million
Q3 2018

Nov 09, 2018

SELL
$105.42 - $114.99 $137,783 - $150,291
-1,307 Reduced 3.1%
40,804 $4.4 Million
Q2 2018

Jul 12, 2018

BUY
$97.35 - $113.14 $376,549 - $437,625
3,868 Added 10.11%
42,111 $4.63 Million
Q1 2018

May 07, 2018

SELL
$96.42 - $107.88 $42,810 - $47,898
-444 Reduced 1.15%
38,243 $3.84 Million
Q4 2017

Feb 12, 2018

BUY
$90.86 - $100.24 $502,728 - $554,627
5,533 Added 16.69%
38,687 $3.81 Million
Q3 2017

Nov 07, 2017

SELL
$91.96 - $108.35 $125,433 - $147,789
-1,364 Reduced 3.95%
33,154 $3.11 Million
Q2 2017

Aug 08, 2017

BUY
N/A
34,518
34,518 $3.84 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Fjarde Ap Fonden Portfolio

Follow Fjarde Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.